08:36 AM EDT, 05/01/2024 (MT Newswires) -- Bio-Techne ( TECH ) reported fiscal Q3 adjusted earnings Wednesday of $0.48 per diluted share, down from $0.53 a year earlier.

Analysts polled by Capital IQ expected $0.46.

Net sales for the quarter ended March 31 was $303.4 million, up from $294.1 million a year earlier.

Analysts surveyed by Capital IQ expected $292.8 million.

Shares of the life sciences company were up more than 7% in recent Wednesday premarket activity.

Price: 67.99, Change: +4.78, Percent Change: +7.56